OBJECTIVE: To investigate the hormonal regulation of P450 aromatase activity (responsible for the conversion of C19 androgens to C18 oestrogens) in human adipose tissue from men and pre-and post-menopausal women. SUBJECTS: Subcutaneous abdominal adipose tissue was obtained from 19 subjects: six pre-menopausal females (mean age 41.8 AE (s.e.m.) 2.5; mean weight 76.01 AE 5.6 kg), eight post-menopausal females (mean age 59.9 AE 2.0; mean weight 63.5 AE 2.6 kg), and ®ve males (mean age 35.8 AE 8.8; mean weight 78.5 AE 7.8 kg) undergoing elective or cosmetic surgery. MEASUREMENTS: Cell viability and cell size were determined using staining techniques. RT-PCR was used to con®rm the presence of aromatase. The regulation of aromatase activity was characterized using androstenedione as a substrate in a tritiated water release assay. Aromatase activity was analysed in abdominal subcutaneous stromal cells (ASC) and mature adipocytes (AD) cultured in serum-free medium with cortisol (10 76 ± 10 77 M), insulin (500 nM) or a combination of both. RESULTS: In ASC aromatase activity increased in females from 14.5 AE 1.7 to 29.3 AE 2.6 pmolamgah (n 14, P`0.05) and to 25.2 AE 2.1 pmolamgah with cortisol (10 77 M) and insulin, respectively (P`0.05). In males ASC basal aromatase activity (20.5 AE 4.2 pmolamgah; n 5) was inhibited by cortisol (10 77 M) alone (12.3 AE 1.8 pmolamgah) and in combination with insulin (6.6 AE 1.2 pmolamgah; men vs women, P`0.005). Aromatase activity in mature adipocytes was stimulated by cortisol plus insulin (P`0.05) with no gender-speci®c differences. Treatment of ASC from both pre-and post-menopausal females with cortisol alone (10 76 M; 10 77 M) or in combination with insulin demonstrated signi®cantly different aromatase regulation compared with male aromatase stromal cell regulation (P`0.05); however there were no differences in aromatase regulation between pre-and post-menopausal females either in stromal cells or adipocytes. CONCLUSION: This study shows intrinsic gender differences in the regulation of aromatase, suggesting that differential enzyme regulation may affect sex steroid metabolism to alter the pattern of fat distribution between the sexes.
Introduction
The distribution of body fat has a major impact on the complications of being obese. Central obesity is associated with adverse metabolic risk factors for cardiovascular disease such as insulin resistance, glucose intolerance, hypertension and dyslipidaemia. 1 ± 3 The pathogenetic mechanisms underlying this link are still poorly understood. Clinical observation of the differences in body fat distribution between the two sexes, however, and changes in fat distribution observed in hyperandrogenic women and hypogonadal males, implicate sex steroids as important candidate factors. 4, 5 Earlier studies examining the role of sex steroids in regional obesity have been hampered by the fact that most common animal models are inappropriate, as sex steroid metabolism is signi®cantly different from humans. This is particularly important in the case of humans where the bulk of required sex steroids are synthesized in peripheral tissues (40% of oestrogen in pre-menopausal women, 100% in post-menopausal women) from adrenal precursor sex steroids such as DHEA and androstenedione. 6, 7 Sex steroids are synthesised through the co-ordinated action of enzymes including aromatase and 17-b-hydroxysteroid dehydrogenase (17bHSD). 7, 8 The tissue-speci®c expression of aromatase is achieved mainly by tissue-speci®c alternative usage of different promoters activated by hormones, class I cytokines and growth. 9 ± 12 Furthermore, characterization of the aromatase P450 gene upstream of the adipose speci®c promoter, exon I. 4 , has shown that it contains a glucocorticoid response element (GRE). 13 The presence of this GRE is of special interest in light of the in vivo data on patients with Cushing's syndrome in whom there is accumulation of abdominal fat. Additional in vitro data determined that abdominal fat shows high activity of 11-b-hydroxysteroid dehydrogenase, 14 and hence there is local cortisol production in fat. 15 Previous in vitro studies investigating the regulation of aromatase activity in abdominal stromal cells (ASC) from females have shown that aromatase expression is increased by dexamethasone in medium containing serum. 16 ± 18 Furthermore both oestrogens and glucocorticoids have been shown to enhance adipose stromal cell proliferation and differentiation. 19, 20 In light of these in vivo and in vitro data we hypothesize that local oestrogen production, through the activity of the enzyme aromatase, may alter preadipocyte proliferation and contribute to gender-speci®c differences in fat distribution. The aims of this study were to examine aromatase expression in both male and female (pre-and post-menopausal) subcutaneous fat and to investigate whether there were gender-speci®c differences in its regulation by glucocorticoids and insulin.
Materials and methods

Tissue culture
Subcutaneous abdominal adipose tissue was obtained from 19 subjects: six pre-menopausal females (mean age 41.8AE (s.e.m.) 2.5; mean weight 76.01AE 5.6 kg), eight post-menopausal females (mean age 59.9 AE 2.0; mean weight 63.5AE 2.6 kg), and ®ve males (mean age 35.8AE 8.8; mean weight 78.5 AE 7.8 kg) undergoing elective surgery or cosmetic surgery in accordance with guidelines of the local hospital ethical committee. Subjects on endocrine therapy (eg steroids, thyroxine) or anti-hypertensive therapy were excluded.
Fresh abdominal subcutaneous adipose tissue (1 ± 2 g wet weight) was collected. Tissue was initially washed with lÂ Hank's balanced salt solution (HBSS) containing penicillin (100 unitsaml) and streptomycin (100 mgaml). Visible blood vessels and connective tissue were removed, and the tissue ®nely chopped. All adipose tissue was digested with the same batch of collagenase class 1 (2 mgaml, Worthington Biochemical Corporation) in lÂ HBSS (Gibco, UK) for 1 h at 37 C in a water bath and shaken at 100 cyclesamin at 37 C. 21 The disrupted tissue was ®ltered through a double-layered cotton mesh. The stromal cells and adipocytes were separated by centrifugation at 360 g for 5 min.
Stromal cell isolation
Stromal cells were resuspended in lysis buffer (0.154 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA) for 10 min to remove erythrocyte contamination and centrifuged at 360 g for 5 min. The pellets of the stromal cells were plated in tissue-culture dishes in Dulbecco's MEMaNutrient mix F-12 (DMEM:F12; GibcoBRL Life Technology, UK) medium supplemented with 15% foetal bovine serum. After 20 h the medium was changed. Stromal cells were cultured in serum-free conditions in DMEM:F12, containing transferrin (5 mgaml), penicillin (100 unitsamin) and streptomycin (100 mgaml) for 6 ± 10 days until conuent in varying concentrations of cortisol (10 76 ± 10 78 M) and insulin (500 nM).
Mature adipocytes isolation
Following centrifugation, the upper layer of mature adipocytes was removed from the collagenase-dispersed preparation and washed in DMEM:F12 twice and centrifuged at 360 g for 2 min. Adipocytes were maintained for 20 h at 37 C in a 5% CO 2 incubator in DMEM:F12 (containing 1% bovine serum albumin (BSA), insulin removed and lipid adsorbed (First Links UK), penicillin (100 unitsaml) and streptomycin (100 mgaml)) before being plated into tissue-culture dishes in DMEM:Fl2 1% BSA. Adipocytes were maintained in medium containing varying concentrations of cortisol (10 76 ± 10 78 M) and insulin (500 nM; Sigma, UK; receiving identical treatment regimens and conditions as the stromal cells) for 72 h before addition of 20 pmol [1b-3 H]-androst-4-ene-3, 17 dione (Du Pont NEN). Both cell types were continually exposed to cortisol and insulin. Cyclodextran water-soluble cortisol (Sigma, UK) was used for all experiments.
Viability of adipocytes was assessed using a dye exclusion method (Sigma, UK). 22 For assessment of adipocyte viability an aliquot of compact adipocyte cells was resuspended in Trypan Blue dye (Sigma UK), containing phosphate buffered saline (PBS; Sigma, UK) and water. The mixture containing the cells was vortexed gently and left for 5 min. Adipocyte cell viability was assessed by removing a uniform aliquot of the mix (containing the adipocytes) to a haemocytometer and counting the proportion of adipocytes that contained blue dye within the cell compared with those that remained viable and absent of blue dye. Adipocyte size was assessed by removing aliquots of adipocytes and photographing the cells. Between 100 ± 200 adipocyte cell diameters, per sample, were determined.
Cellular staining
For assessment of endothelial contamination, subcutaneous stromal cells were stained for factor VIII (Sigma, UK), a known marker of endothelial cells, according to a previously described method. 23 In brief, cells were ®xed in 10% formalin and hydrogen peroxide was used to block endogenous peroxidase activity. Subsequently cells were incubated with goat Gender regulation of aromatase PG McTernan et al serum for 10 min, washed with PBS for 10 min, and incubated overnight with factor VIII primary antibody (1a50; rabbit anti-human; Sigma, UK) diluted in PBS.
To detect bound antibody, cells were incubated with the secondary antibody for 1 h (1a100; anti-rabbit biotin conjugated; Dako, Denmark). After additional washes with PBS (twice, 5 min each) cells were visua1ized using 0.05% (wav) 3,3 H -diaminobenzidine tetra-hydrochioride (DABCO; Sigma, UK,) in PBS with 0.01% hydrogen peroxide. Cells were lightly counterstained with haematoxylin.
Enzyme assays
Aromatase activity was measured using a tritiated water release assay by incubating intact stromal cells and adipocytes in serum-free medium (4 and 14 h, respectively) with 20 pmol [1b-
3 H]-androst-4-ene-3, 17 dione (Du Pont NEN, speci®c activity 24.3 Ciammol). Each experiment was carried out in triplicate and activity expressed as mean AE s.e. pmol or fmolamg, proteinah as previously reported. 14 
Protein assay
Protein in each incubate was determined using the Bradford method (Bio-rad, UK). 24 As adipocytes were maintained in medium containing 1% BSA separate culture tissue dishes were maintained in the absence of BSA to assess protein levels.
Reverse-transcriptase PCR
RNA was extracted using an RNeasy kit (Quigen, UK) from subcutaneous stromal cells and adipocytes. One microgram of total RNA was incubated with 0.5 mg random primer for 5 min at 70 C, and reverse transcribed. The PCR product was ampli®ed with aromatase primers and required 95 C 5 min 1 cycle; 94 C 1 min; 50 C 1 min; 72 C 1 min, for 30 cycles. A 433 base pair product within the coding region was ampli®ed using the sense oligo (5 H -TCC.TTG.CAC. CCA.GAT.GAG.ACT-3 H ) and antisense oligo (5 H -TCG.GGT.CTT.TTA.TGG.ATA.CGC-3 H ). 14 PCR products were visualised on a 1% agarose gel.
Statistical analysis
Statistical analysis was undertaken using unpaired ttests for analysis of male vs female treatment (Tables   2 and 3 ) and by ANOVA for comparison of control versus treatments for both male and female subjects ( Figure 3 ; Table 1 ). Data are presented as mean AE s.e.m.
Results
Assessment of stromal and adipocyte function
Expression of aromatase by RT-PCR con®rmed previous PCR analysis of presence of aromatase within abdominal adipose tissue (Figure 1) . Samples of stromal cells were morphologically stained and determined absent from endothelial contamination (Figure 2 ). Adipocytes were assessed to be b 99% viable using the dye exclusion method (Figure 2 ). Adipocyte size was assessed and determined in male adipocytes (88.36AE 1.07 mm), premenopausal adipocytes (94.73AE 0.94 mm) and postmenopausal adipocytes (87.56AE 1.24 mm). Upon statistical analysis no signi®cant difference in adipocyte size was observed between the three groups.
Regulation of aromatase expression: effect of gender and cortisol
Stromal cells. There was no signi®cant difference in basal aromatase activity in ASC from males (20.6 AE 4.2 pmolamgah) compared with females (14.6 AE 1.8 pmolamgah) ( Figure 3A ; Table 1 ). Incubation with cortisol revealed a dose-dependent inhibition of aromatase activity in male ASC. By contrast, stimulation of aromatase activity was observed in female ASC (Table 1, Figure 3A ). 
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Adipocytes. Aromatase activity in adipocytes was consistently found, but was at least 10-fold less than that observed in ASC. No gender differences were observed ( Figure 3B ). In contrast however to ASC, cortisol with insulin stimulated aromatase activity in both sexes (F 10 76 M insulin 500 nM; P`0.005).
With increasing doses of insulin (500 nM) no alteration of activity was observed in male or female ASC or adipocytes (data not shown). No synergistic response was observed between insulin and glucocorticoids in ASC or adipocytes from either sex.
Regulation of aromatase expression: effect of age and menopausal state
Stromal cells and adipocytes. Basal ASC aromatase activity from pre-and post-menopausal females were not signi®cantly different (13.4AE 6.3 pmolamgah, 15.3AE 2.7 pmolamgah, respectively). Cortisol signi®-cantly increased aromatase activity in both pre-(F 10 77 M: 23.7AE 1.9 pmolamgah; P`0.001) and postmenopausal (F 10 77 M: 32.6AE 4.0 pmolamgah; P`0.001) ASC, but menopausal status did not affect this stimulatory response (Table 2) . Additionally, four post-menopausal females from the study were receiving hormone replacement therapy. Their ASC demonstrated a similar pattern of aromatase as both the pre-and post-menopausal women ( Table 2) . Comparison of adipocytes from subjects receiving hormone replacement therapy to pre-, post-menopausal females revealed no individual pattern of aromatase regulation between the sub-groups (Table 3) . Basal aromatase activity in ASC was reduced with advancing age; however, this was not signi®cantly altered by either sex or menopausal state (Figure 4 ). Weight was not signi®cantly different between the subgroups.
Discussion
While several studies have in the past tackled the question of aromatase regulation in adipose tissue the issue of gender has not been rigorously addressed. Previous research on the regulation of aromatase activity has only examined female cohorts and thus not analysed gender differences. While the data from our female subjects con®rm ®ndings of previous investigators, the data on the regulation of aromatase Figure 2 Abdominal subcutaneous stromal cells (A) and endothelial cells (B) were stained to indicate their distinctive morphology. ASC were absent of endothelial contamination when stained using factor VIII (C) whilst omental stromal cell samples containing endothelial cells were used as a positive control (D) (positive: brownanegative: blue). Isolated male (E) and female (F) adipocytes were assessed as b 99% viable using the exclusion dye method. Original magni®cationÂ100 (A, C ± F) or Â200 (B). Figure 3 Regulation of aromatase activity in subcutaneous ASC (A) or AD (B) by cortisol (F) and insulin (500 nM) in males (n 5) and females (n 14). Activity is expressed as mean AE s.e.m. pmolamg proteinah. Statistical analysis compared basal with treatments (stimulation ( ) or inhibition ( 7 )) for male and females by ANOVA (*P`0.05, **P`0.005).
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in stromal cells taken from male patients, in whom increasing cortisol concentrations inhibited aromatase activity, represent a novel ®nding. Studies by Macdonald and co-workers did not demonstrate any signi®cant gender differences in total aromatase activity as re¯ected by urinary excretion of tritiated oestrone. 25, 26 Their studies, however, did not attempt to address the question of regulation nor did they examine aromatase activity in situations of glucocorticoid excess (ie Cushing's syndrome). The potential importance of aromatase expression in regulating adipose tissue mass has been highlighted by recent studies on the aromatase knockout mouse, 27 in which the loss of subcutaneous adipose tissue was observed. These studies are supported by in vivo data in man in which de®ciency in aromatase expression, results in tall stature with eunuchoid body proportions. 28 In this study a gender-speci®c pattern of enzyme regulation by glucocorticoids within abdominal adipose tissue is observed. Further evidence supporting a gender-speci®c pattern of regulation of abdominal adipose tissue metabolism has been provided by studies examining the regulation of leptin production by dexamethasone and oestradiol. 29 Although not addressed in this study the possibility of site speci®c regulation is clearly an important issue and will require further investigation.
In an attempt to further investigate the effect of hormonal state, abdominal subcutaneous adipose tissue was examined from pre-and post-menopausal females. The regulation of aromatase activity by cortisol was unaffected by menopausal state in both stromal cells and adipocytes. This highlights the ®ndings of previous investigators 30 suggesting that circulating oestrogen levels do not in¯uence the regulation of aromatase activity by glucocorticoids. In fact in vivo data suggests that it is total body metabolic processes and their relation to secretion of C19 pre-hormones that determines sex hormone production. 25 Similar conclusions may be drawn from our studies on adipose tissue obtained from females on hormone replacement therapy, although more extensive investigation will be required. Despite the statistically non-signi®cant differences in body weight between the two cohorts, we examined adipocyte cell size to determine the in¯uence of cell size on aromatase activity. Pre-menopausal females had a tendency to weigh more than the post-menopausal females, however, adipocytes size was unaltered between the two groups. Furthermore adipocyte size was unaltered by gender. Table 2 Pre-and post-menopausal females, and post-menopausal females receiving hormone replacement therapy (HRT) subcutaneous stromal cells were assessed for the pattern of aromatase regulation by cortisol (F) and insulin. Statistical analysis by unpaired t-test compared subject groups relative aromatase activity, expressed as mean AE s.e. pmolamg proteinah for each treatment. No signi®cant difference between the three groups was observed. Each number per group was assessed in triplicate for aromatase activity Figure 4 Expression of basal aromatase activity of cultured subcutaneous stromal cells (ASC) from males (d) and females (m) as a function of age. Activity is expressed as mean pmolamg proteinah. The regression line was calculated using Statview Software (correlation coef®cient r 2 0.21), basal aromatase activity was reduced with advancing age. Basal aromatase activity was not signi®cantly altered by either sex or menopausal state.
Previous data have shown an increase in aromatase activity with age, 25, 30 however our present study failed to demonstrate this. The different methodological approaches to assess aromatase activity may account for the variance in results. Previous investigators using either in vivo data, 25 mRNA from fresh uncultured samples, 31 or cultured stromal cells for a maximal period of 18 h have shown an increased aromatase activity with age. 30 The stromal cells in this study were, however, cultured for a minimum period of six days while the adipocytes were maintained for 3 days. The adipocytes were maintained in short term serum-free culture system as they were prone to lysis when incubated in serum-free medium for any longer periods of time. Previous investigators have not observed changes in adipocyte metabolism over time, as such it is unlikely that the different time exposures to cortisol and insulin experienced by the stromal cells and adipocytes account for the patterns of regulation observed. 32 We believe, therefore, that our data accurately measure changes in intrinsic age and cell dependent regulation of aromatase activity by glucocorticoids and insulin.
The concentration of insulin in which the cells were incubated re¯ects its rapid inactivation at 37 C, as up to 90% of insulin is destroyed within an hour of its addition to serum-free medium. 33 Despite previous reports suggesting insulin plays an important role in adipocyte proliferation and differentiation, 34 the results of this study suggest that its mode of action does not involve activation of aromatase.
An extensive body of work by Simpson and his colleagues has demonstrated aromatisation of androgens into oestrogens within adipose tissue. 16 ± 18 Their earlier work highlighted aromatase expression in the adipocyte fraction although this was later attributed to stromal cell contamination. 18 In this study adipocytes were puri®ed from stromal cells by washes and centrifugation. We were unable to detect aromatase activity in cultured stromal cells when less than 30% con¯uent (data not shown); suggesting that it is unlikely that contamination with a few stromal cells would explain the observed aromatase activity in adipocytes. This is further re-enforced by our data from a cortisol dose response study in which differences in relative expression of aromatase between the sexes were observed in adipocytes. The regulation of aromatase activity identi®ed in the stromal cell fraction also appears to be very different to that observed in the adipocyte fraction and photographs taken of each adipocyte sample for assessment of cell viability failed to demonstrate the presence of any stromal cells. As such we believe our data accurately re¯ects adipocyte aromatase activity. Adipocytes do, however, have considerably less aromatase activity than stromal cells per milligram of protein, and as such their in¯uence on circulating levels may be minimal. Nevertheless, as adiposity increases this adipocyte aromatase expression may result in important paracrine effects such as enhanced stromal cell proliferation, differentiation and hence enhanced adiposity.
In conclusion, we have demonstrated a genderspeci®c pattern of aromatase regulation by cortisol in ASC. Cortisol stimulates aromatase activity in ASC from females, increasing oestrogen production, with the opposite observed in males, in whom there is inhibition of aromatase activity and reduced oestrogen production. Two different mechanisms may operate within the sexes to explain the different roles of cortisol in aromatase regulation. In females, aromatase activity increases, by addition of cortisol, to enhance oestrogens to maintain their gynoid pattern of fat distribution, through proliferation and differentiation by oestrogens. 19, 20 This pattern of regulation is not altered by menopausal status, suggesting that the change in distribution in body fat which occurs with the menopause is mediated by another mechanism. In males a second mechanism may operate to reduce cortisol production and thus oestrogen production through aromatase regulation, which may lead to inhibition in the formation of a gynoid pattern of fat distribution. This study therefore highlights one possible gender-speci®c mechanism to account for the characteristic patterns of fat distribution observed in the two sexes.
